Fontanetta Ron
Towers Perrin's HR Services, New York, USA.
Benefits Q. 2005;21(3):17-9.
With Medicare set to begin offering a prescription drug benefit in 2006, employers that provide medical coverage to retirees aged 65 and older have a unique opportunity to redefine their programs and financial commitments for the long term. The new Medicare Part D drug benefit poses a range of alternatives for employers to consider--from eliminating post-65 drug benefits altogether to maintaining or modifying their current programs to qualify for the 28% federal tax subsidy for eligible drug costs. In deciding on a course of action, companies need to consider a host of complex issues, including workforce needs and demographics, employee relations, plan design and administration--in addition to the long-term financial and accounting implications. This article reviews the alternatives available to employers with the advent of Medicare Part D and highlights some of the key factors employers should consider as part of this decision.
随着医疗保险计划将于2006年开始提供处方药福利,为65岁及以上退休人员提供医疗保险的雇主迎来了一个独特的契机,可长期重新定义其医保计划及财务投入。新的医疗保险D部分药物福利为雇主提供了一系列可供考虑的选择——从完全取消65岁以上人员的药物福利,到维持或修改其现有计划以符合 eligible drug costs的28%联邦税收补贴条件。在决定行动方针时,公司除了要考虑长期财务和会计影响外,还需考虑一系列复杂问题,包括劳动力需求和人口统计数据、员工关系、计划设计与管理等。本文回顾了随着医疗保险D部分的出现雇主可选择的方案,并强调了雇主在这一决策过程中应考虑的一些关键因素。 (注:原文中“eligible drug costs”未明确给出具体释义,暂保留英文。)